EP3285742A4 - Plättchenförmige proteo-mikropartikel und verfahren zur verwendung davon in der arzneimittelverabreichung - Google Patents

Plättchenförmige proteo-mikropartikel und verfahren zur verwendung davon in der arzneimittelverabreichung Download PDF

Info

Publication number
EP3285742A4
EP3285742A4 EP16782388.9A EP16782388A EP3285742A4 EP 3285742 A4 EP3285742 A4 EP 3285742A4 EP 16782388 A EP16782388 A EP 16782388A EP 3285742 A4 EP3285742 A4 EP 3285742A4
Authority
EP
European Patent Office
Prior art keywords
proteo
microparticles
platelet
drug delivery
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16782388.9A
Other languages
English (en)
French (fr)
Other versions
EP3285742A1 (de
Inventor
Patrick C. H. Hsieh
Bill Cheng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Academia Sinica
Original Assignee
Academia Sinica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academia Sinica filed Critical Academia Sinica
Publication of EP3285742A1 publication Critical patent/EP3285742A1/de
Publication of EP3285742A4 publication Critical patent/EP3285742A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5063—Compounds of unknown constitution, e.g. material from plants or animals
    • A61K9/5068—Cell membranes or bacterial membranes enclosing drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP16782388.9A 2015-04-20 2016-04-20 Plättchenförmige proteo-mikropartikel und verfahren zur verwendung davon in der arzneimittelverabreichung Pending EP3285742A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562149849P 2015-04-20 2015-04-20
PCT/AU2016/000135 WO2016168884A1 (en) 2015-04-20 2016-04-20 Platelet-like proteo-microparticles and method of using such in drug delivery

Publications (2)

Publication Number Publication Date
EP3285742A1 EP3285742A1 (de) 2018-02-28
EP3285742A4 true EP3285742A4 (de) 2018-11-21

Family

ID=57142766

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16782388.9A Pending EP3285742A4 (de) 2015-04-20 2016-04-20 Plättchenförmige proteo-mikropartikel und verfahren zur verwendung davon in der arzneimittelverabreichung

Country Status (6)

Country Link
US (1) US10835493B2 (de)
EP (1) EP3285742A4 (de)
JP (1) JP6874995B2 (de)
CN (1) CN107847442B (de)
TW (1) TWI651092B (de)
WO (1) WO2016168884A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109157513B (zh) * 2018-07-27 2020-11-06 湖北大学 一种血栓靶向长循环缓释脂质体及其制备方法
EP3739321B1 (de) * 2019-05-17 2023-03-08 Xtal Concepts GmbH Qualifizierungsverfahren für kryoelektronenmikroskopie-proben sowie dazugehöriger probenhalter

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5238919A (en) * 1986-05-30 1993-08-24 Scipps Clinic And Research Foundation Peptides that inhibit von Willebrand Factor binding to the platelet SPIB receptor
US5503982A (en) * 1993-09-30 1996-04-02 Research Corporation Technologies, Inc. Detection of an acute myocardial infarction in a patient
JP3735921B2 (ja) * 1996-02-07 2006-01-18 三菱ウェルファーマ株式会社 ＧＰＩｂ・脂質複合体およびその用途
CN1318035C (zh) 2003-09-18 2007-05-30 中国人民解放军军事医学科学院野战输血研究所 一种人血小板代用品及其制备方法
JP5216219B2 (ja) * 2006-01-06 2013-06-19 真司 武岡 薬物運搬体
WO2007077990A1 (ja) * 2006-01-06 2007-07-12 Keio University 薬物運搬体
EP2018436A2 (de) * 2006-04-25 2009-01-28 Immune Disease Institute Inc. Gezielte abgabe an leukozyten mit nicht-proteinträgern
US8512697B2 (en) * 2007-05-16 2013-08-20 The University Of North Carolina At Chapel Hill Delivery of micro- and nanoparticles with blood platelets
US20100151573A1 (en) * 2008-11-17 2010-06-17 King Michael R Compositions and methods for delivery of molecules to selectin-ligand-expressing and selectin-expressing cells
US9107845B2 (en) * 2011-04-13 2015-08-18 Case Western Reserve University Synthetic platelets
CA2873404C (en) * 2011-06-02 2022-08-30 The Regents Of The University Of California Membrane encapsulated nanoparticles and method of use
US9107963B2 (en) 2012-04-13 2015-08-18 Case Western Reserve University Heteromultivalent nanoparticle compositions
US20140186431A1 (en) * 2013-01-03 2014-07-03 Temple University - Of The Commonwealth System Of Higher Education Combined mesenchymal stem cell transplantation and targeted delivery of vegf for treatment of myocardial infarction

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHARLES J HAMORI ET AL: "Targeting Zinc Protoporphyrin Liposomes to the Spleen Using Reticuloendothelial Blockade with Blank Liposomes", PEDIATRIC RESEARCH, vol. 34, no. 1, 1 July 1993 (1993-07-01), US, pages 1 - 5, XP055503925, ISSN: 0031-3998, DOI: 10.1203/00006450-199307000-00001 *
EUGENE JANG, HASSAN ALBADAWI, MICHAEL T. WATKINS, ELAZER R. EDELMAN, AARON B. BAKER: "Syndecan-4 proteoliposomes enhance fibroblast growth factor-2 (FGF-2)-induced proliferation, migration, and neovascularization of ischemic muscle", PNAS, vol. 109, no. 5, 31 January 2012 (2012-01-31), XP002785710 *
See also references of WO2016168884A1 *

Also Published As

Publication number Publication date
JP2018513170A (ja) 2018-05-24
EP3285742A1 (de) 2018-02-28
US10835493B2 (en) 2020-11-17
CN107847442A (zh) 2018-03-27
US20180092846A1 (en) 2018-04-05
TW201641118A (zh) 2016-12-01
JP6874995B2 (ja) 2021-05-19
CN107847442B (zh) 2021-03-16
WO2016168884A1 (en) 2016-10-27
TWI651092B (zh) 2019-02-21

Similar Documents

Publication Publication Date Title
IL248730B (en) Drug delivery system and method of use
EP3386484A4 (de) Zusammensetzungen und verfahren zur abgabe von therapeutischen wirkstoffen
IL287749A (en) Compositions for administering implantable drugs and methods of their use
HK1254909A1 (zh) 藥物納米粒子的傳送及其使用方法
EP3294398A4 (de) System und verfahren zur verabreichung von arzneimitteln
EP3250258A4 (de) Verfahren und systeme zur wirkstofffreisetzung
EP3355954A4 (de) Freisetzungsverfahren und zusammensetzungen
EP3142735A4 (de) Vorrichtungen und verfahren zur identifizierung von medikamentenabgabevorrichtungen
EP3125866A4 (de) Nachfüllbare wirkstofffreisetzungsvorrichtungen und verfahren zur verwendung davon
EP3137153A4 (de) Transdermale wirkstofffreisetzungsvorrichtung und verfahren
EP3437637A4 (de) Pharmazeutische zubereitung von palbociclib und herstellungsverfahren dafür
EP3250681A4 (de) Zusammensetzungen und verfahren zur t-zell-freisetzung von therapeutischen peptiden
AU2015346450B2 (en) Expandable drug delivery devices and method of use
EP3180044A4 (de) Implantierbares therapeutisches abgabesystem und verfahren dafür
EP3148494A4 (de) Wirkstofffreisetzungssysteme und zugehörige verfahren zur verwendung
EP3380525A4 (de) Pharmazeutische formulierungen und verfahren zur verwendung davon
EP3191972A4 (de) Medikamentenabgabesystem und -verfahren
IL251443A0 (en) Compositions and methods for coating with cannabinoids for drug delivery
EP3212595A4 (de) Explosive zusammensetzung und bereitstellungsverfahren
EP3290034A4 (de) Verwendung von trimethazin in der herstellung von arzneimitteln zur prävention und behandlung von leberkrankheiten
EP3560518A4 (de) Komplex zur verabreichung und stabilisierung von arzneimitteln und verfahren zur herstellung davon
EP3377004A4 (de) Vorrichtung und verfahren zur verbesserten wirkstofffreisetzung
EP3658083A4 (de) Abgabevorrichtung und verfahren zur abgabe
EP3573604A4 (de) Modulares system zur transdermalen verabreichung und zugehörige verfahren zur herstellung und verwendung
EP3115040A4 (de) Mizelle mit blasen zur arzneimittelverabreichung und verfahren zur herstellung davon

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171113

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20181024

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 9/10 20060101ALI20181017BHEP

Ipc: A61K 31/409 20060101ALI20181017BHEP

Ipc: A61K 9/127 20060101AFI20181017BHEP

Ipc: A61K 31/24 20060101ALI20181017BHEP

Ipc: A61K 9/14 20060101ALI20181017BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210907